Feed / CHRN

ChronoScale Holdings Corporation

CHRN

Technology · 18.01 -0.5% today

Isolated · not yet confirmedMarket checked 10 Sept, 15:55 GMT-4

Market read

ChronoScale Holdings Corporation's current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 29 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.

Company-0.5% todayVolume comparison unavailable
Market group0 of 29 activeSemiconductor Manufacturing · unavailable
Disclosed network0 of 1 confirmingNo filing-linked name is confirming now
What would change this read
  • CHRN's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if CHRN's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Technology · Information Technology Services

No new filing conclusion is available. 0 of 29 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • CHRN's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations188
Usable filing statements69
Verified relationships2
Evidence supporting the case
  • Latest annual revenue changed +459.4% year over year.
  • Operating margin changed +51.8 percentage points in the latest annual period.
  • Net margin changed +21.1 percentage points in the latest annual period.
Evidence challenging the case
  • Credit and interest rates has repeated adverse evidence across 4 filings.
  • Restructuring and cost reductions has repeated adverse evidence across 4 filings.
  • Product pipeline and R&D has repeated adverse evidence across 3 filings.
Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Sep 10, 2026

18.01
6m+77.3%12m24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2023-12-31$18.3M+41.6%$-1.10+7.0%
2024-12-31$17.9M-1.9%$-8.43+45.4%
2025-05-31$84.4M+370.7%$-0.53
2025-12-31$12.8M-84.8%$-4.91
2026-05-31$71.6M+459.4%$-0.36

What management says matters

Persistent and emerging business drivers

Credit and interest ratesnegative · 4 filings
Riley Promissory Note and lower interest income from lower cash deposits, partially offset by lower interest expense related to the Parker Hannifin Promissory Note.
10-Q · Apr 28, 2026
Restructuring and cost reductionsnegative · 4 filings
Research and development expenses decreased $0.4 million, or 41%, for the three months ended March 31, 2026, compared to the same period of 2025, primarily due to lower headcount and the absence of severance expense.
10-Q · Apr 28, 2026
Product pipeline and R&Dnegative · 3 filings
Research and development expenses decreased $0.4 million, or 41%, for the three months ended March 31, 2026, compared to the same period of 2025, primarily due to lower headcount and the absence of severance expense.
10-Q · Apr 28, 2026
Supply chain and availabilitymixed · 3 filings
Three months ended March 31, 2026 2025 Net cash used in operating activities $ (2,123 ) $ (1,965 ) Net cash used in investing activities — (10 ) Net cash provided by financing activities 4,952 3,529 Effect of exchange rate changes on cash (5 ) 7 Net increase…
10-Q · Apr 28, 2026

Valuation discipline

Peer-relative valuation withheld

Jodie found no industry-matched filing peers suitable for a valuation comparison. It will not substitute broader financial-sector names.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

18.01-0.5% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for CHRN. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for CHRN. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind CHRN

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

OBOCYFiling-linked namepartnerApr 28, 2026

In support of this effort, to date we have signed agreements with National Seating & Mobility for selling exclusivity into the Complex Rehabilitation Technology segment, with Bionic Prosthetics & Orthotics Group, a respected O&P provider serving 14 states, an…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

CHRN is currently a Early Follower in the organic co-movement group Semiconductor Manufacturing. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for CHRN; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.